Clinical Trial Update: Functional Connectivity as a Biomarker of rTMS [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating functional connectivity as a biomarker for rTMS in traumatic brain injury; trial completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Traumatic Brain Injury | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-04-12